• FDA Issues EUA for Convalescent Plasma as Potential Promising COVID–19 Treatment
  The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the use of investigational convalescent plasma to treat serious coronavirus patients.
  in Public bookmarks with administration and authorization convalescent coronavirus covid-19 drug emergency fda food plasma the use vaccine

convalescent from all users